NO872462L - Fremgangsmaate ved fremstilling av nye, antihypertensive midler. - Google Patents

Fremgangsmaate ved fremstilling av nye, antihypertensive midler.

Info

Publication number
NO872462L
NO872462L NO872462A NO872462A NO872462L NO 872462 L NO872462 L NO 872462L NO 872462 A NO872462 A NO 872462A NO 872462 A NO872462 A NO 872462A NO 872462 L NO872462 L NO 872462L
Authority
NO
Norway
Prior art keywords
acid
solution
agents
oil
salts
Prior art date
Application number
NO872462A
Other languages
English (en)
Norwegian (no)
Other versions
NO872462D0 (no
Inventor
Gary A Flynn
Douglas W Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO872462D0 publication Critical patent/NO872462D0/no
Publication of NO872462L publication Critical patent/NO872462L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO872462A 1986-06-13 1987-06-12 Fremgangsmaate ved fremstilling av nye, antihypertensive midler. NO872462L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87393986A 1986-06-13 1986-06-13

Publications (2)

Publication Number Publication Date
NO872462D0 NO872462D0 (no) 1987-06-12
NO872462L true NO872462L (no) 1987-12-14

Family

ID=25362652

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872462A NO872462L (no) 1986-06-13 1987-06-12 Fremgangsmaate ved fremstilling av nye, antihypertensive midler.

Country Status (11)

Country Link
EP (1) EP0249224A3 (de)
JP (1) JPS62298592A (de)
KR (1) KR880000400A (de)
CN (1) CN87104167A (de)
AU (1) AU7402387A (de)
DK (1) DK300287A (de)
FI (1) FI872612L (de)
IL (1) IL82812A0 (de)
NO (1) NO872462L (de)
PT (1) PT85071A (de)
ZA (1) ZA874106B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
DE69220744T2 (de) * 1991-09-27 1997-11-13 Merrell Pharma Inc 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
AU668707B2 (en) * 1992-02-14 1996-05-16 Merrell Pharmaceuticals Inc. Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
DE69329701T2 (de) * 1992-10-30 2001-05-10 Merrell Pharmaceuticals Inc., Cincinnati Mercaptoacetylamid substituiertes bizyclisches laktam zur verwendung als enkephalinase und ace-hemmer
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
DE69516128T2 (de) * 1994-02-14 2000-12-21 Merrell Pharmaceuticals Inc., Cincinnati Mercaptoacetylamid-1,3,4,5-tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
CN1142831A (zh) * 1994-02-14 1997-02-12 默里尔药物公司 用作脑啡肽酶和ace抑制剂的新的2-取代的1，2-二氢化茚-2-巯基乙酰胺二硫化物衍生物
ATE177098T1 (de) * 1994-02-14 1999-03-15 Merrell Pharma Inc Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
HUT74584A (en) * 1994-02-14 1997-01-28 Merrell Pharma Inc Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
ATE189392T1 (de) * 1994-03-24 2000-02-15 Merrell Pharma Inc Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
FI963784A0 (fi) * 1994-03-24 1996-09-23 Merrell Pharma Inc Hypokolesteroleemisiä, antiateroskleroottisia ja hypotriglyserideemisiä merkaptoasetyyliamididisulfidijohdannaisia
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166354B1 (de) * 1984-06-26 1992-08-05 Merck & Co. Inc. Kondensierte Benzo-Laktam-Verbindungen und deren pharmazeutische Zusammensetzungen
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents

Also Published As

Publication number Publication date
EP0249224A3 (de) 1989-01-25
IL82812A0 (en) 1987-12-20
DK300287A (da) 1987-12-14
DK300287D0 (da) 1987-06-12
EP0249224A2 (de) 1987-12-16
CN87104167A (zh) 1988-01-20
PT85071A (en) 1987-07-01
KR880000400A (ko) 1988-03-25
FI872612A0 (fi) 1987-06-11
JPS62298592A (ja) 1987-12-25
NO872462D0 (no) 1987-06-12
ZA874106B (en) 1987-12-08
FI872612A7 (fi) 1987-12-14
FI872612L (fi) 1987-12-14
AU7402387A (en) 1987-12-17

Similar Documents

Publication Publication Date Title
NO872462L (no) Fremgangsmaate ved fremstilling av nye, antihypertensive midler.
EP0249223B1 (de) Antihypertensives Mittel
US4584294A (en) Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
US4973585A (en) Tricyclic lactams active as antihypertensive agents
US4477464A (en) Hetero-benzazepine derivatives and their pharmaceutical use
AU676501B2 (en) Benzo-fused lactams promote release of growth hormone
EP0107095B1 (de) 1-N-Carboxyalkylbenzolaktame, brauchbar als antihypertensive Mittel
US5438136A (en) Benzo-fused macrocycles promote release of growth hormone
EP0079522B1 (de) Antihypertonische N-Carboxymethyl(amidino)-lysyl-prolin-Wirkstoffe
HU193288B (en) Process for production of substituated derivatives of lactane
EP0068173B1 (de) Perhydro-1,4-thiazepin-5-one und Perhydro-1,4-thiazocin-5-one, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4409146A (en) Substituted caprolactam derivatives as antihypertensives
CH671397A5 (de)
EP0046289B1 (de) Substituierte Önantholactam-Derivate als Antihypertonika, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Zusammensetzung und Zwischenprodukte
US4594341A (en) Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives as antihypertensives
US4617301A (en) Sulfoxide and sulfone derivatives of bicyclic lactams as antihypertensives
FR2467845A1 (fr) Nouveaux derives mercapto-acyles de prolines 4,4-disubstituees et de dehydroprolines 4-substituees, utiles notamment comme medicaments hypotenseurs, compositions therapeutiques et formes pharmaceutiques les contenant, et intermediaires utiles pour leur synthese
US4652641A (en) Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
EP0166353B1 (de) Kondensierte Benzo-Laktame welche als antihypertensive Mittel dienen und als Antagonisten von Cholecystokinin
US4520021A (en) Substituted caprolactam derivatives as antihypertensives
US4555503A (en) N2 -(Substituted)carboxymethyl-N6 -(substituted)-lysyl-and αε-aminoalkyl)glycyl amino acid antihypertensive agents
KR20070116970A (ko) 안드로겐 조절제
EP0049505A2 (de) Substituierte Caprolactam-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammenstellungen, die sie enthalten, und Zwischenprodukte
US4396616A (en) Substituted enantholactam derivatives as antihypertensives
EP0049842B1 (de) Substituierte Enantholactam-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammenstellungen, die sie enthalten, zur Anwendung gegen erhöhten Blutdruck und Zwischenprodukte